Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.87
+0.61 (4.60%)
At close: May 4, 2026, 4:00 PM EDT
13.88
+0.01 (0.07%)
After-hours: May 4, 2026, 7:58 PM EDT
Intellia Therapeutics Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$20.02
Upside
+44.34%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $48 → $58 | Strong Buy | Maintains | $48 → $58 | +318.17% | Apr 28, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $8 → $9 | Strong Sell | Maintains | $8 → $9 | -35.11% | Apr 28, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $11 → $15 | Hold | Maintains | $11 → $15 | +8.15% | Apr 28, 2026 |
| Citizens | Citizens | Buy Maintains $28 → $30 | Buy | Maintains | $28 → $30 | +116.29% | Apr 28, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +116.29% | Apr 27, 2026 |
| Baird | Baird | Hold Maintains $7 → $13 | Hold | Maintains | $7 → $13 | -6.27% | Apr 27, 2026 |
| Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $29 | Hold → Strong Buy | Upgrades | $29 | +109.08% | Mar 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $54 → $48 | Strong Buy | Maintains | $54 → $48 | +246.07% | Mar 3, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +109.08% | Mar 3, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $15 | Hold | Maintains | $9 → $15 | +8.15% | Mar 3, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | +8.15% | Mar 3, 2026 |
| Citizens | Citizens | Buy Maintains $21 → $28 | Buy | Maintains | $21 → $28 | +101.87% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +116.29% | Mar 3, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 → $27 | Strong Buy | Maintains | $26 → $27 | +94.66% | Mar 2, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +87.45% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +80.25% | Jan 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.